Nov 11 (Reuters) - Zalicus Inc said it would stop developing an experimental pain drug after it failed to show a benefit over a placebo in two mid-stage trials.
The drug, called Z160, was being developed for treating chronic pain. Zalicus said it now planned to focus on another pain drug, Z944.
The company's shares were halted in pre-market trading. They closed at $4.69 on Friday on the Nasdaq.
Super Micro Computer's lack of a preliminary earnings report led to a bloodbath in the sector.
Costco made buying a gold bar as simple as tossing it in a shopping cart. Adam Xi, 33 years old, called five different dealers to get a price he could accept for the gold bar he bought at Costco in October. Costco shoppers are spending as much as $200 million monthly on gold, according to a Wells Fargo estimate.
This company has been around for decades, but the recent AI boom has supercharged growth.
The buying opportunity for semiconductor stock investors might be around the corner.
These two stocks both have safe yields topping 8%.
Suppose you have a $3 million brokerage account and a $3 million tax-deferred retirement account. Your daughter, who already is in a high tax bracket under her salary, will pay tax on every dollar she pulls out of the retirement account. The Salvation Army, meanwhile, won’t pay taxes in either case—whether it receives the retirement account or the brokerage account.
If you are looking to buy good dividend stocks to hold for years to come, this varied trio should be atop your list today.
Crypto bulls are hoping that Bitcoin’s ‘halving’ will be a catalyst for further gains in the world’s largest cryptocurrency.
Seasonality is a factor in the stock market, but it isn't a reason to abandon your long-term investment strategy.
Opportunistic investors can still find growth stocks at a discount, even with the Nasdaq Composite reaching a fresh all-time closing high in April.